使用对比增强FLAIR成像提高小儿脑肿瘤脑脊膜播散的诊断准确性。

IF 2.4 Q2 CLINICAL NEUROLOGY
Neuro-oncology practice Pub Date : 2024-08-12 eCollection Date: 2025-02-01 DOI:10.1093/nop/npae075
Berna Aygun, Asthik Biswas, Mohammed Blaaza, Jessica Cooper, Pritika Gaur, Jernej Avsenik, Harini R Rao, James Stegeman, Ulrike Löbel, Elwira Szychot, Felice D'Arco, Sniya Sudhakar, Kshitij Mankad
{"title":"使用对比增强FLAIR成像提高小儿脑肿瘤脑脊膜播散的诊断准确性。","authors":"Berna Aygun, Asthik Biswas, Mohammed Blaaza, Jessica Cooper, Pritika Gaur, Jernej Avsenik, Harini R Rao, James Stegeman, Ulrike Löbel, Elwira Szychot, Felice D'Arco, Sniya Sudhakar, Kshitij Mankad","doi":"10.1093/nop/npae075","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Central nervous system cancers are a leading cause of childhood cancer-related mortality. Accurate staging and assessment of leptomeningeal spread, particularly in aggressive neoplasms such as embryonal tumors, is crucial for treatment planning and prognosis. Conventional diagnostic methods, relying on magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology, have limitations, including high false-negative rates and sensitivity issues. In this retrospective study, we aim to compare the diagnostic sensitivity of contrast-enhanced T2-weighted fluid-attenuated inversion recovery (CE-T2W-FLAIR) and 2D and 3D contrast-enhanced T1-weighted imaging (CE-T1WI) for detecting leptomeningeal disease.</p><p><strong>Methods: </strong>We retrospectively reviewed 1372 MRI brain studies of 297 patients aged 1-19 years. We included only those MRI examinations adhering to our neuro-oncology protocol while excluding incomplete or suboptimal studies. A control group without leptomeningeal disease was matched for disease and age. Three groups of 2 neuroradiologists each, blinded to case status, reviewed the images using various sequences. The results were compared using the McNemar test and chi-squared test for <i>P</i>-values.</p><p><strong>Results: </strong>The sensitivity of CE-T2W-FLAIR sequence was significantly higher compared with that of CE-T1WI (<i>P</i> = .025). There was no statistically significant difference between the sensitivity of 2D CE-T1WI and 3D CE-T1WI (<i>P</i> = .3173). The specificity of the 3D CE-T1WI was significantly lower compared with those of CE-T2W-FLAIR and 2D CE-T1WI (<i>P</i> = .014). The positive predictive values for CE-T2W-FLAIR, 2D CE-T1WI, and 3D CE-T1WI were 100%, 100%, and 68.4%, respectively, whereas the negative predictive values were 100%, 85.7%, and 85.71%, respectively.</p><p><strong>Conclusions: </strong>The inclusion of CE-T2W-FLAIR in the MRI protocol improves sensitivity and specificity in diagnosing leptomeningeal spread in pediatric brain tumors.</p>","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":"12 1","pages":"51-57"},"PeriodicalIF":2.4000,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798603/pdf/","citationCount":"0","resultStr":"{\"title\":\"Improved diagnostic accuracy for leptomeningeal dissemination in pediatric brain tumors using contrast-enhanced FLAIR imaging.\",\"authors\":\"Berna Aygun, Asthik Biswas, Mohammed Blaaza, Jessica Cooper, Pritika Gaur, Jernej Avsenik, Harini R Rao, James Stegeman, Ulrike Löbel, Elwira Szychot, Felice D'Arco, Sniya Sudhakar, Kshitij Mankad\",\"doi\":\"10.1093/nop/npae075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Central nervous system cancers are a leading cause of childhood cancer-related mortality. Accurate staging and assessment of leptomeningeal spread, particularly in aggressive neoplasms such as embryonal tumors, is crucial for treatment planning and prognosis. Conventional diagnostic methods, relying on magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology, have limitations, including high false-negative rates and sensitivity issues. In this retrospective study, we aim to compare the diagnostic sensitivity of contrast-enhanced T2-weighted fluid-attenuated inversion recovery (CE-T2W-FLAIR) and 2D and 3D contrast-enhanced T1-weighted imaging (CE-T1WI) for detecting leptomeningeal disease.</p><p><strong>Methods: </strong>We retrospectively reviewed 1372 MRI brain studies of 297 patients aged 1-19 years. We included only those MRI examinations adhering to our neuro-oncology protocol while excluding incomplete or suboptimal studies. A control group without leptomeningeal disease was matched for disease and age. Three groups of 2 neuroradiologists each, blinded to case status, reviewed the images using various sequences. The results were compared using the McNemar test and chi-squared test for <i>P</i>-values.</p><p><strong>Results: </strong>The sensitivity of CE-T2W-FLAIR sequence was significantly higher compared with that of CE-T1WI (<i>P</i> = .025). There was no statistically significant difference between the sensitivity of 2D CE-T1WI and 3D CE-T1WI (<i>P</i> = .3173). The specificity of the 3D CE-T1WI was significantly lower compared with those of CE-T2W-FLAIR and 2D CE-T1WI (<i>P</i> = .014). The positive predictive values for CE-T2W-FLAIR, 2D CE-T1WI, and 3D CE-T1WI were 100%, 100%, and 68.4%, respectively, whereas the negative predictive values were 100%, 85.7%, and 85.71%, respectively.</p><p><strong>Conclusions: </strong>The inclusion of CE-T2W-FLAIR in the MRI protocol improves sensitivity and specificity in diagnosing leptomeningeal spread in pediatric brain tumors.</p>\",\"PeriodicalId\":19234,\"journal\":{\"name\":\"Neuro-oncology practice\",\"volume\":\"12 1\",\"pages\":\"51-57\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11798603/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro-oncology practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/nop/npae075\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:中枢神经系统癌症是儿童癌症相关死亡的主要原因。准确的脑脊膜扩散分期和评估,特别是在侵袭性肿瘤如胚胎肿瘤中,对治疗计划和预后至关重要。传统的诊断方法,依赖于磁共振成像(MRI)和脑脊液(CSF)细胞学,有局限性,包括高假阴性率和敏感性问题。在这项回顾性研究中,我们的目的是比较对比增强t2加权液体衰减反转恢复(CE-T2W-FLAIR)和2D和3D对比增强t1加权成像(CE-T1WI)对小脑膜疾病的诊断敏感性。方法:回顾性分析297例1 ~ 19岁患者的1372份脑MRI研究。我们只纳入那些符合我们神经肿瘤学方案的MRI检查,而排除了不完整或次优的研究。另设无轻脑膜疾病的对照组,按疾病和年龄相匹配。三组每组2名神经放射学家,不知道病例状态,使用不同的序列检查图像。采用McNemar检验和卡方检验对p值进行比较。结果:CE-T2W-FLAIR序列的敏感性显著高于CE-T1WI序列(P = 0.025)。2D CE-T1WI与3D CE-T1WI的敏感性差异无统计学意义(P = .3173)。3D CE-T1WI的特异性明显低于CE-T2W-FLAIR和2D CE-T1WI (P = 0.014)。CE-T2W-FLAIR、2D CE-T1WI、3D CE-T1WI的阳性预测值分别为100%、100%、68.4%,阴性预测值分别为100%、85.7%、85.71%。结论:在MRI方案中纳入CE-T2W-FLAIR可提高诊断小儿脑肿瘤脑膜轻脑膜扩散的敏感性和特异性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Improved diagnostic accuracy for leptomeningeal dissemination in pediatric brain tumors using contrast-enhanced FLAIR imaging.

Background: Central nervous system cancers are a leading cause of childhood cancer-related mortality. Accurate staging and assessment of leptomeningeal spread, particularly in aggressive neoplasms such as embryonal tumors, is crucial for treatment planning and prognosis. Conventional diagnostic methods, relying on magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology, have limitations, including high false-negative rates and sensitivity issues. In this retrospective study, we aim to compare the diagnostic sensitivity of contrast-enhanced T2-weighted fluid-attenuated inversion recovery (CE-T2W-FLAIR) and 2D and 3D contrast-enhanced T1-weighted imaging (CE-T1WI) for detecting leptomeningeal disease.

Methods: We retrospectively reviewed 1372 MRI brain studies of 297 patients aged 1-19 years. We included only those MRI examinations adhering to our neuro-oncology protocol while excluding incomplete or suboptimal studies. A control group without leptomeningeal disease was matched for disease and age. Three groups of 2 neuroradiologists each, blinded to case status, reviewed the images using various sequences. The results were compared using the McNemar test and chi-squared test for P-values.

Results: The sensitivity of CE-T2W-FLAIR sequence was significantly higher compared with that of CE-T1WI (P = .025). There was no statistically significant difference between the sensitivity of 2D CE-T1WI and 3D CE-T1WI (P = .3173). The specificity of the 3D CE-T1WI was significantly lower compared with those of CE-T2W-FLAIR and 2D CE-T1WI (P = .014). The positive predictive values for CE-T2W-FLAIR, 2D CE-T1WI, and 3D CE-T1WI were 100%, 100%, and 68.4%, respectively, whereas the negative predictive values were 100%, 85.7%, and 85.71%, respectively.

Conclusions: The inclusion of CE-T2W-FLAIR in the MRI protocol improves sensitivity and specificity in diagnosing leptomeningeal spread in pediatric brain tumors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信